Follow-The-Filings

Security · featured owners

IMMX Immix Biopharma Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 2.2%
  • $24M
  • 1 new

Who owns this now

Largest portfolio weights among featured holders · max 2.2% (James Silverman - Opaleye Management) · not free-float ownership

  1. James Silverman new 2.2%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
James Silverman - Opaleye Management 2026 Q2 2.2% New 2.2% 2,345,000 $24M history

1 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Net income -$15.43M -$21.61M -$29.44M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $19.79M $20.2M $101.24M
Total non-current assets * $0.137M $2.75M $3.6M
Total assets $19.93M $22.95M $104.84M
Total current liabilities $3.72M $8.69M $10.11M
Total non-current liabilities * $0M $1.01M $0.934M
Total equity $16.41M $13.25M —

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$11.37M -$14.6M -$23.93M
Cash from investing -$0.052M -$1.18M -$7.21M
Cash from financing $15.46M $15.95M $107.39M
Net change in cash $4.07M $0.172M $76.25M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders

Q2 2026

period archive